Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer. - Han X; Song L; Feng Y; Wang Z; Wang L; Liu R; Liu Y; Li N; Ma S; Lu F; Yang J; Huang Z; et al. (Cell death & disease, 2026)